Scientists at the University of Surrey have discovered that a natural antioxidant commonly found in green tea can help eliminate antibiotic resistant bacteria.
The study, published in the Journal of Medical Microbiology, found that epigallocatechin (EGCG) can restore the activity of aztreonam, an antibiotic commonly used to treat infections caused by the bacterial pathogen Pseudomonas aeruginosa.
P. aeruginosa is associated with serious respiratory tract and bloodstream infections and in recent years has become resistant to many major classes of antibiotics. Currently a combination of antibiotics is used to fight P. aeruginosa. However, these infections are becoming increasingly difficult to treat, as resistance to last line antibiotics is being observed.
To assess the synergy of EGCG and aztreonam, researchers conducted in vitro tests to analyse how they interacted with the P. aeruginosa, individually and in combination. The Surrey team found that the combination of aztreonam and EGCG was significantly more effective at reducing P. aeruginosa numbers than either agent alone.
This synergistic activity was also confirmed in vivo using Galleria mellonella (Greater Wax Moth larvae), with survival rates being significantly higher in those treated with the combination than those treated with EGCG or aztreonam alone. Furthermore, minimal to no toxicity was observed in human skin cells and in Galleria mellonella larvae.
Researchers believe that in P. aeruginosa, EGCG may facilitate increased uptake of aztreonam by increasing permeability in the bacteria. Another potential mechanism is EGCG’s interference with a biochemical pathway linked to antibiotic susceptibility.
Lead author Dr Jonathan Betts, Senior Research Fellow in the School of Veterinary Medicine at the University of Surrey, said: “Antimicrobial resistance (AMR) is a serious threat to global public health. Without effective antibiotics, the success of medical treatments will be compromised. We urgently need to develop novel antibiotics in the fight against AMR. Natural products such as EGCG, used in combination with currently licenced antibiotics, may be a way of improving their effectiveness and clinically useful lifespan.”
Professor Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases in the School of Veterinary Medicine at the University of Surrey, said: “The World Health Organisation has listed antibiotic resistant Pseudomonas aeruginosa as a critical threat to human health. We have shown that we can successfully eliminate such threats with the use of natural products, in combination with antibiotics already in use. Further development of these alternatives to antibiotics may allow them to be used in clinical settings in the future.”
The Latest on: Antibiotic resistant bacteria
via Google News
The Latest on: Antibiotic resistant bacteria
- Japan had over 8,000 deaths related to drug-resistant bacteria in 2017on December 5, 2019 at 1:58 pm
More than 8,000 people in Japan are estimated to have died due to two major antibiotic-resistant bacteria in 2017, a research team said Thursday. The first survey conducted on a national level ...
- Thousands die in Japan due to overuse of antibiotics, research showson December 5, 2019 at 11:12 am
Dec. 5 (UPI) --More than 8,000 people die annually from antibiotic-resistant bacteria in Japan. Japanese researchers at the Center Hospital of the National Center for Global Health and Medicine said ...
- Drug-resistant bacteria killed over 8,000 in Japan in 2017, researchers estimateon December 5, 2019 at 2:35 am
a research team said Thursday that more than 8,000 people nationwide are estimated to have died due to two major drug-resistant bacteria in 2017. The first such survey conducted on a national level ...
- ‘I feel constant pain’: drug resistance adds to misery of Gaza gun victimson December 5, 2019 at 2:08 am
The suffering of people wounded in conflict zones is being compounded by what doctors say are ‘horrifying levels’ of antibiotic resistance ...
- Q&A: Genetic testing can identify antibiotic resistanceon December 5, 2019 at 2:05 am
This is a problem because, the more broad-spectrum antibiotics in the environment, the greater the selective pressure for bacteria to evolve and develop resistance, which raises the bar for successful ...
- Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infectionson December 5, 2019 at 12:34 am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial ...
- U.S. continues to lead the fight against antibiotic resistanceon December 4, 2019 at 2:09 pm
It’s antibiotic resistance: the potential failure of one ... like the fungus Candida auris and “nightmare” bacteria like carbapenem-resistant Enterobacteriaceae, that have yet to become common in the ...
- Antibiotic-resistant bacteria are killing us. Here's how we can defeat these 'superbugs.'on December 3, 2019 at 8:07 am
Bacteria become resistant to antibiotics in a textbook evolution process. Let's see if vaccines, drug combinations or reduced doses can slow it down.
- Bacteria known to develop resistance to antibioticson December 2, 2019 at 7:58 pm
Washington: While suffering from viral fever or bacterial infection, the first thing one does is to take antibiotics. Some bacteria develop resistance to otherwise effective treatment with antibiotics ...
- Do past medicines hold the answer to antibiotic resistance?on November 30, 2019 at 4:28 am
Researchers think that this treatment method may be worth a modern reexamination. Share on Pinterest Scientists are exploring new avenues for tackling the antibiotic resistance crisis. As an ...
via Bing News